Vastera
Seoul · Founded 2018
About Vastera
Bastera is a biotech company with the primary goal of developing groundbreaking treatments for cardiovascular and cancer diseases. Their approach involves targeting new redox signaling pathways, aiming to pioneer "first-in-class" therapies in these fields. Vastera was established in 2018 when SangWon Kang, a professor at Ewha Womans University, transferred a patent based on research results on redox signaling in blood vessels and cancer.
Company Facts
- Founded: 2018
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $19.9M
- Funding stage: Early Stage Venture
- Last round: Series B (Mar 2022)
- Website: http://vasthera.com/
Industries & Categories
Biotechnology, Health Care, Life Science
Canonical: https://fsome.com/organization/vastera-98607 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.